BHC
Bausch Health Companies Inc

41,868
Mkt Cap
$1.84B
Volume
2.07M
52W High
$8.69
52W Low
$4.25
PE Ratio
11.97
BHC Fundamentals
Price
$4.96
Prev Close
$5.05
Open
$5.10
50D MA
$6.22
Beta
1.15
Avg. Volume
2.04M
EPS (Annual)
$0.4187
P/B
-3.32
Rev/Employee
$495,942.03
$23,292.15
Loading...
Loading...
News
all
press releases
Q2 EPS Forecast for Bausch Health Cos Decreased by Analyst
Bausch Health Cos Inc. (NYSE:BHC - Free Report) - Equities research analysts at Zacks Research decreased their Q2 2027 earnings estimates for Bausch Health Cos in a research note issued on Wednesday...
MarketBeat·22h ago
News Placeholder
More News
News Placeholder
Zacks Research Issues Positive Estimate for TSE:BHC Earnings
Bausch Health Companies Inc. (TSE:BHC - Free Report) - Stock analysts at Zacks Research upped their Q2 2026 EPS estimates for shares of Bausch Health Companies in a report issued on Wednesday, March...
MarketBeat·1d ago
News Placeholder
Zacks Research Has Pessimistic View of TSE:BHC Q1 Earnings
Bausch Health Companies Inc. (TSE:BHC - Free Report) - Equities researchers at Zacks Research dropped their Q1 2026 earnings estimates for shares of Bausch Health Companies in a note issued to...
MarketBeat·2d ago
News Placeholder
Zacks Research Expects Lower Earnings for Bausch Health Cos
Bausch Health Cos Inc. (NYSE:BHC - Free Report) - Investment analysts at Zacks Research decreased their Q1 2026 earnings per share estimates for Bausch Health Cos in a report issued on Wednesday...
MarketBeat·2d ago
News Placeholder
Bausch Health Companies (TSE:BHC) Stock Price Down 1.1% - Here's What Happened
Bausch Health Companies (TSE:BHC) Trading Down 1.1% - Time to Sell...
MarketBeat·4d ago
News Placeholder
RSI Alert: Bausch Health Companies (BHC) Now Oversold
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Nasdaq News: Markets·8d ago
News Placeholder
Bausch Health Cos (NYSE:BHC) Price Target Cut to $7.00 by Analysts at Barclays
Barclays decreased their price target on shares of Bausch Health Cos from $8.00 to $7.00 and set an "equal weight" rating for the company in a research note on Wednesday...
MarketBeat·17d ago
News Placeholder
Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant Touch Laser in Canada
Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant Touch Laser in Canada Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear...
PR Newswire·19d ago
News Placeholder
Ironwood vs. Bausch Health: Which GI Drug Stock is a Better Pick Now?
IRWD has the edge over BHC with high Linzess demand and upbeat 2026 revenue outlook offsetting pipeline and pricing risks.
Zacks·22d ago
News Placeholder
BHC Stock Down on Q4 Earnings Miss, Salix Drives Revenue Growth
Bausch stock slips as Q4 EPS misses despite 9% revenue growth, strong Salix and Bausch + Lomb gains, and an upbeat 2026 sales outlook.
Zacks·23d ago
<
1
2
...
>

Latest BHC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.